Intended for healthcare professionals
Guideline

Chinese expert consensus on the diagnosis and treatment of female primary pelvic retroperitoneal tumours (2025 edition)

Female primary pelvic retroperitoneal tumours (PPRTs) refer to a heterogeneous group of tumours originating from the retroperitoneal space of the female pelvis, located predominantly or entirely within the true pelvis. This group excludes metastatic tumours, bone-derived tumours, extragastrointestinal stromal tumours, broad ligament myomas, endometriosis, tumours originating from the lymphoreticular system and tumours originating from pelvic visceral organs (such as those of the female reproductive tract, intestines and urinary system). PPRTs, also known as pelvic extraperitoneal tumours, have an incidence rate of less than 0.01%. The upper boundary of the pelvic retroperitoneal space is defined by a line consisting of the superior border of the symphysis pubis, the pubic tubercle and the superior border of the sacral promontory, whereas the inferior boundary extends to the pelvic diaphragm or below. Most female PPRTs are diagnosed during reproductive age, with approximately 80% of the tumours being benign.1 The management of PPRTs poses challenges for general clinicians due to their limited clinical experience, which leads to a high rate of missed cases and misdiagnoses. Compared with abdominal retroperitoneal tumours, the anatomical structure of PPRTs is deeper and more complex, resulting in greater surgical difficulty. Currently, there is a lack of relevant guidelines or consensus regarding diagnosis and treatment.2 Therefore, the Chinese Society of Gynaecologic Oncology, Chinese Medical Association and the Gynaecologic Oncology Group of the Branch of Obstetricians and Gynaecologists, Chinese Medical Doctor Association formulated this consensus after extensive discussions among experts in gynaecologic oncology, pathology and colorectal surgery, along with a review of domestic and international literature, to improve the diagnosis and treatment of female PPRTs. Importantly, this consensus is based primarily on the consistency of expert opinions, as high-quality research evidence is currently lacking.

The evidence retrieval was conducted based on the identified clinical problems and the principles of Population, Intervention, Control, Outcome. The recommendation levels and their meanings in this consensus are shown in table 1.

Table 1
Recommendation levels and implications for this consensus

Aetiology and classification

Female PPRTs have numerous potential origins, although their aetiology remains unclear. According to a comprehensive review of the literature and the WHO classification of soft tissue tumours, PPRTs can be categorised into congenital, mesenchymal, neurogenic and mixed tumours, as shown in table 2.1 3 4 Among these categories, congenital tumours are the most prevalent and may arise from embryonic residual tissues.

Table 2
Histopathological classification of female PPRTs

PPRT was previously classified into three types on the basis of tumour position in the pelvis by Ming et al.5 Type I tumours are located at the foramen magnum, type II tumours are located posterior to the pubis and type III tumours are found in the presacral region. Currently, a revised anatomical classification for female PPRTs is proposed following discussions among experts in gynaecological oncology, colorectal surgery and related fields. In this classification, type I tumours are located in the posterior pelvic cavity, also known as the retrorectal or presacral space. Type II tumours are positioned laterally within the pelvic cavity, which includes the lateral bladder space, lateral vaginal space, broad ligament (excluding fibroids within the broad ligament), and perirectal space. Type III tumours are located in the anterior pelvic cavity (posterior to the pubis), also referred to as the Retzius space. Finally, type IV tumours are categorised as mixed tumours, which can be located in both the posterior and lateral pelvic cavities or in both the lateral and anterior pelvic cavities (see figures 1 and 2).

Anatomical structure of female PPRTs. PPRTs, primary pelvic retroperitoneal tumours.

MRI of female PPRTs (red asterisks refer to tumour). PPRTs, primary pelvic retroperitoneal tumours.

Recommendations: The aetiology of female PPRTs remains unclear. We propose the following anatomical classification of tumours: Type I tumours are located in the posterior pelvic cavity, also referred to as the retrorectal or presacral space. Type II tumours are located laterally within the pelvic cavity and encompass the lateral bladder space, lateral vaginal space, broad ligament (excluding fibroids in the broad ligament) and perirectal space. Type III tumours are found in the anterior pelvic cavity (posterior to the pubis), commonly known as the Retzius space. Finally, type IV tumours are classified as mixed tumours, which are located in both the posterior and lateral pelvic cavities or in both the lateral and anterior pelvic cavities. (Category 2B).

Clinical manifestations

Symptoms

The symptoms of female PPRTs vary on the basis of tumour location, tumour size, infection and extent of compression or involvement of surrounding organs. Generally, small tumours are asymptomatic; however, as they grow, compressive symptoms may develop. For example, rectal compression may lead to difficulties with defecation, whereas urinary system compression can result in dysuria or urinary irritation. Furthermore, compression of nerve plexuses may cause pain or numbness in the buttocks and legs. Additionally, a minority of patients may report abdominal pain or bloating. Presacral tumours that compress the rectum can affect anal sphincter sensation. Moreover, if presacral tumours are associated with infection, they may lead to a range of symptoms, including altered anal sphincter sensation, persistent purulent discharge from the sacrococcygeal region or perianal area, and recurrent anal fistulas or perianal abscesses, often necessitating repeated surgical interventions.6 7

Physical examination

Patients presenting to the hospital with pelvic masses should undergo a comprehensive physical examination. It is crucial for both diagnosis and differential diagnosis to evaluate the location, characteristics and mobility of the tumour and its relationship with the uterus, adnexa, bladder, rectum, sacrococcygeal region and pelvic wall during bimanual examination, triad examination or digital rectal examination. Abdominal examination often proves inadequate for detecting PPRTs, as tumours typically localise posteriorly or laterally to the rectum and exhibit poor mobility during triad or digital rectal examinations. Furthermore, PPRTs are closely associated with the pelvic wall, rendering them immobile when the uterus is displaced. Occasionally, the urethra or rectum may be compressed and displaced due to the tumour, and in some patients, the cervix becomes difficult to visualise owing to this compression.

Recommendations: Female patients with PPRT typically present with nonspecific symptoms, and compressive or occupying symptoms may emerge as the tumour enlarges. A triad examination or a digital rectal examination is recommended for all suspected patients, particularly for those who are not sexually active. (Category 2A).

Imaging manifestations and laboratory indices

Tumour markers

PPRTs originate from a complex assembly of tissues, including connective tissue, adipose tissue, nerves, lymphatic tissue and embryonic residual tissue. Currently, non-specific tumour markers can offer valuable differential diagnostic information. A minority of teratomas may occasionally exhibit elevated levels of CEA, CA19-9 and CA-125.8 9 Overall, gynaecological tumour markers have limited utility in the diagnosis of female PPRTs; however, they are effective in excluding ovarian malignant tumours.

Imaging manifestations

Ultrasonography is the most commonly used imaging modality in gynaecology because of its simplicity, accuracy, cost-effectiveness and real-time dynamic capabilities. However, the interpretation of imaging findings in the diagnosis of PPRTs is significantly influenced by the sonographer’s experience. The following signs may suggest the presence of a PPRT: (1) the tumour remains immobile regardless of the patient’s breathing, positional changes or external forces, as the location of PPRTs is typically fixed and deep; (2) the tumour is generally located posteriorly or laterally to the rectum, exhibiting a clear boundary from the adnexa and uterus while being closely associated with the pelvic wall; (3) large vessels may be compressed or displaced, and the distance between them may increase if the tumour is of considerable size and (4) the sliding sign between the tumour and adjacent pelvic organs serves as a crucial indicator of a PPRT.10–13 Transabdominal ultrasound offers limited diagnostic value in distinguishing intraperitoneal masses from retroperitoneal masses, resulting in a high rate of missed diagnoses due to inadequate spatial resolution and susceptibility to interference from intestinal gas and abdominal wall fat.14 In contrast, transvaginal or rectal ultrasound provides superior diagnostic value, yielding higher-resolution images and a closer proximity to the tumour, thus mitigating the effects of intestinal gas and abdominal fat. This technique allows for a clearer assessment of the tumour’s size, morphology, location, internal structure, blood flow and relationship with surrounding tissues. Nevertheless, for large PPRTs located high in the pelvis, the utility of transvaginal or rectal ultrasonography is limited, increasing the risk of missed diagnoses. Ultrasonography can dynamically illustrate the entire process of tumour perfusion in real time using microbubble contrast agents, capturing key features such as 'fast in and fast out’ to differentiate between benign and malignant tumours. Additionally, it aids in evaluating the feasibility of surgical intervention by delineating the boundary between the tumour and surrounding tissues, as well as highlighting the encirclement or invasion of adjacent blood vessels.

Compared with ultrasound, CT and MRI offer a broader range of examinations and relatively higher resolution, effectively identifying tumour morphology, boundaries, tissue invasion and relative position. These imaging modalities provide critical references for surgical approaches. Enhanced MRI exhibits superior resolution for soft tissues, clearly illustrating the relationships between tumours and adjacent organs and blood vessels, as well as distinguishing different components within the tumour, aiding in the identification of various tumour types. Furthermore, MRI can be used to evaluate invasion into the intervertebral foramen, nerves and other tissues. The following signs may indicate the presence of a PPRT: (1) the uterus or rectum, exhibiting clear boundaries, is compressed and displaced anteriorly or medially by the tumour; (2) the iliac vessels are compressed and either displaced or encased by the tumour and (3) the pelvic wall muscles are compressed by the tumour.

CT provides significant diagnostic value for teratomas because it clearly demonstrates tissue calcification and bone destruction. Furthermore, contrast-enhanced CT of the chest, pelvis and abdomen is essential for staging pelvic retroperitoneal malignant tumours. Positron emission tomography/CT integrates the anatomical and metabolic information of tumours, enabling whole-body screening and assisting in the detection of metastatic tumours. Overall, it plays a crucial role in the diagnosis, clinical staging and treatment of primary pelvic retroperitoneal malignant tumours. Three-dimensional CT reconstruction technology offers a comprehensive evaluation of the spatial relationships between PPRTs and surrounding structures, including blood vessels, nerves and bones. Digital subtraction angiography also provides valuable information for surgical planning by assessing the tumour’s blood supply and the involvement of surrounding blood vessels.

Recommendations: Ultrasound is the most commonly used imaging modality for diagnosing PPRTs. Enhanced pelvic MRI is recommended as the first-line examination for PPRT (category 2A).

Biopsy

Surgical excision remains the primary treatment option for female patients with PPRTs, and biopsy is generally contraindicated in cases of resectable PPRTs. The accuracy of preoperative biopsy for detecting cystic PPRTs is limited, potentially resulting in tumour rupture and implantation metastasis. Conversely, while the accuracy of biopsy for solid PPRTs is relatively high, there remains a risk of implantation metastasis.15 A biopsy may be considered in the following scenarios: (1) patients with suspected metastatic tumours or other tumours identified during imaging examinations where surgery is not the primary treatment option and (2) patients with tumours that exhibit malignant characteristics on imaging studies, particularly when surgical resection is challenging or when the patient may face serious complications postsurgery.16

Recommendations: Biopsy is not routinely recommended for patients with suspected PPRT. (Category 2A).

Diagnosis and differential diagnosis

The diagnosis of female PPRTs relies primarily on physical examination and imaging studies because of the absence of specific tumour markers.15 All women of reproductive age presenting with a pelvic mass should undergo a triad examination or a digital rectal examination, particularly women who are not sexually active. PPRTs should be suspected when the mass demonstrates poor mobility, is closely associated with the pelvic wall and has no connection to the uterus or adnexa, potentially leading to compression and displacement of the urethra, rectum, cervix and other surrounding tissues. Imaging studies are essential to assess the relationship between the mass and the pelvic organs or the pelvic wall, thereby excluding tumours that originate from bone or pelvic organs. It is crucial to differentiate PPRTs from the following diseases:

Ovarian tumours

PPRTs are frequently misdiagnosed as adnexal masses. In contrast to benign ovarian tumours, which typically exhibit good mobility and no association with the pelvic wall, PPRTs demonstrate limited mobility and a close relationship with the pelvic wall. Additionally, while patients with ovarian carcinoma present with poor tumour mobility and elevated levels of tumour markers such as CA 125, CA 19-9 and HE 4, PPRTs lack specific tumour markers. A comprehensive diagnostic evaluation is essential to assess the relationship between the tumour and surrounding tissues, particularly for tumours located distant from the uterus. PPRTs should be considered in cases of tumours located laterally or posteriorly to the rectum or in instances where tumours are not detected during bimanual examination. Imaging studies serve as valuable tools for identifying PPRTs, which are characterised by their well-defined borders in relation to the uterus and adnexa.

Uterine fibroids

Female PPRTs may be misdiagnosed as broad ligament or cervical fibroids. Uterine leiomyomas typically present as solid masses in imaging examinations and exhibit good mobility and a close relationship with the uterus during physical examinations. In contrast, PPRTs may appear as either solid or cystic masses in imaging studies and demonstrate poor mobility and a close relationship with the pelvic wall during physical examinations. CT or MRI examinations can provide more accurate information regarding the tumour location and a clearer understanding of the relationship between the tumour and the uterus.

Perianal abscess/anal fistula

A perianal abscess is characterised by symptoms of infection, including heat, swelling, pain and acute discomfort. Additionally, patients may experience a fluctuating sensation accompanied by pain around the rectum during rectal palpation. In contrast, presacral cysts are more prevalent in young and middle-aged women and typically present only with fluctuating sensations, without any signs of infection. Presacral cysts that are infected may be misdiagnosed as perianal abscesses or anal fistulas. These cysts are located anterior to the sacrococcygeal region and posterior to the rectum and generally do not damage the anal sphincter. In contrast, perianal abscesses are typically located lower and adjacent to the anal sphincter. Physicians should consider the possibility of presacral cysts in patients with recurrent perianal abscesses or anal fistulas who have undergone multiple surgeries.

Sacrococcygeal tumours

Sacrococcygeal tumours must be differentiated from PPRTs, as they tend to grow anteriorly and project into the pelvis. Typically, sacrococcygeal tumours present with bone destruction and soft tissue masses on imaging, whereas most PPRTs show no evidence of bone destruction and maintain clear borders with the sacrococcygeal bone.

Lymphohaematopoietic system tumours

Lymphohaematopoietic system tumours may present with multiple enlarged lymph nodes and systemic symptoms, including fever, night sweats and weight loss. In contrast, PPRTs are typically isolated masses. Furthermore, tumours originating from the lympho-haematopoietic system may present with abnormal blood counts and bone marrow test results, which are generally not detectable in PPRT patients. Additionally, the typical imaging presentation of lymphoma is a homogeneous soft tissue mass, whereas a PPRT tends to exhibit varied density or signal characteristics.

Deep infiltrating endometriosis

Deep infiltrating endometriosis is frequently associated with a history of dysmenorrhoea and dyspareunia and is generally not easily confused with PPRTs. Additionally, deep infiltrating endometriosis may present with a ’shadow sign’ (indicative of old bleeding) on MRI and elevated levels of CA125. Furthermore, triple examination will suggest that the mass may be located in the rectovaginal septum, sacral ligament or other areas. Typically, PPRTs exhibit nonspecific clinical manifestations and tumour markers, with imaging potentially revealing cystic, cystic-solid or solid-occupying lesions.

Tumours originating from pelvic organs

Tumours originating from the urinary system or intestinal tract typically present with symptoms specific to the affected organ at an earlier stage. In contrast, PPRTs generally lack specific clinical manifestations. During imaging examinations, tumours originating from specific organs often demonstrate structural destruction of the organ, a feature that is not typically observed in PPRTs. However, PPRTs may present with symptoms such as organ compression or displacement. In cases where the tumour is too large to ascertain its origin or when a malignant tumour invades surrounding organs, leading to diagnostic challenges in imaging, a multidisciplinary team (MDT) is recommended.

Recommendations: There is a lack of specific tumour markers for female PPRTs, and the diagnosis is primarily based on physical examination and imaging. (Category 2A).

Treatment

Expectant management

A monitoring approach may be appropriate for asymptomatic patients with good compliance, particularly when the tumour is small, cystic and exhibits no malignant characteristics in imaging studies.

Surgical treatment

Complete surgical resection is the primary treatment for female patients with PPRTs, and benign PPRTs can be effectively cured following complete resection. It is advisable to avoid electrosurgical cauterisation, puncture and drainage, and the injection of sclerosing agents for tumours, as these methods are associated with a high recurrence rate and may compromise the anatomical structure of the tumour, thereby increasing the difficulty of subsequent surgeries. In cases where PPRTs are incidentally detected during laparoscopic or open surgical procedures, performing a biopsy should be strictly avoided, as it may damage the anatomical structure, contaminate adjacent tissues and complicate future surgical interventions. It is strongly recommended that patients be referred to a large, comprehensive hospital with relevant experience to mitigate these risks.

The anatomical structure of the pelvic retroperitoneal space is complex and involves the iliac vessels and their branches, nerves, ureters, intestinal tubes and other critical structures. This space has narrow dimensions, necessitating collaboration among multidisciplinary departments, including gynaecology, colorectal surgery, urology and vascular surgery departments. Patients should be referred to a large comprehensive centre for treatment, as the volume of the centre is associated with surgical outcomes.17 Intraoperative tumour rupture and secondary resection have been identified as independent risk factors for the recurrence of presacral benign tumours.18 Furthermore, initial R0 resection represents a pivotal opportunity for potentially curing malignant PPRTs.19 En bloc resection is recommended for malignant PPRTs to achieve R0 resection, which is characterised by local infiltrative growth and distant metastasis.20

Recommendations: Surgical resection is the primary treatment for female patients with PPRTs (category 1); Biopsy should be avoided for PPRTs detected incidentally during laparoscopic or open surgery, and patients should be referred to a large comprehensive hospital with experience (category 2A); Initial complete resection is recommended for female patients with PPRTs because it affects prognosis. En bloc resection is advised for patients with evidence of organ involvement, and combined surgery can be considered by MDT if necessary (category 2A).

Surgical approach

Female PPRTs can be resected through various surgical approaches. The choice of surgical method and extent of resection depends on factors such as the tumour location, size and nature, and the involvement of the pelvic walls or pelvic organs. Additionally, the technical expertise and proficiency of the surgical team should be considered.

Anterior approach (open surgery, laparoscopic surgery, etc)

Open surgery is typically recommended for PPRTs located laterally in the pelvis or posteriorly for pubic or presacral tumours above the S3 vertebra, provided that there is no invasion of the sacrum. Although this approach offers a larger operating space and facilitates the separation of pelvic organs, it presents challenges in addressing the caudal portion of PPRTs.21 Open surgery remains the predominant surgical approach for retroperitoneal sarcoma due to the large size and complex anatomy of the tumour, which may necessitate combined organ resection.22 Notably, visibility during open surgery is limited for tumours located deep within the pelvis.23

Laparoscopic surgery, which involves both conventional laparoscopy and robot-assisted laparoscopy, offers significant advantages for delicate manipulation within the confined space of the deep pelvis. This technique enhances the visualisation of nerves, blood vessels and surrounding tissues, thereby reducing the risk of injury during procedures.24 25 Certain PPRTs, located below the S3 vertebra and above the levator ani muscle, can be completely resected using laparoscopy, thereby broadening the indications for the anterior approach.3 However, there is a lack of consensus regarding the indications for laparoscopic surgery in the treatment of PPRTs. Most studies suggest that laparoscopic intervention is appropriate for small tumours that exhibit no malignant characteristics on imaging and show no significant invasion of adjacent organs or bone. For solid PPRTs, it is advisable that the tumour diameter not exceed 10 cm, although the size may be adjusted on the basis of the complexity of the surgery and the surgeon’s experience. In the case of cystic tumours, the criteria for minimally invasive surgery can be more lenient, as controlled volume reduction of the tumour can be performed intraoperatively.26 Compared with open surgery, laparoscopic techniques have been shown to improve the surgical field and enhance postoperative recovery.1 Notably, robot-assisted laparoscopic surgery offers additional benefits for cases involving previous surgical failure or recurrent tumour resection, providing greater surgical safety and being particularly well suited for intricate procedures.27 28

Recommendations: For solid PPRTs, laparoscopic surgery is recommended for tumours that are small in size, located above the pelvic floor muscle, exhibit benign characteristics on imaging and show no obvious invasion into surrounding organs or the pelvic wall. In contrast, the indications for cystic PPRTs can be relaxed accordingly. Open surgery is advised for PPRTs located above the S3 vertebra, which demonstrate malignant tendencies characterised by a large size, a predominance of solid components and invasion into surrounding organs, as indicated by imaging examinations. (Category 2B).

Posterior approach (transsacral, transsacrococcygeal, transperineal, transvaginal and others)

The posterior approach is the primary surgical technique for type I PPRTs located below S3. This technique may be associated with complications such as perineal infection or sinus formation. Compared with the anterior approach, the posterior approach facilitates access to the caudal portion of the tumour, resulting in shorter operation times, fewer complications and improved incision healing. This approach is particularly suitable for small type I PPRTs located below S3.6 29 However, it is important to note that there is an increased risk of intraoperative pelvic haemorrhage and lateral pelvic nerve injury due to inadequate vascular visualisation. Therefore, it is essential for the surgeon to possess a thorough understanding of the anatomical structures, maintain a clear surgical field and avoid blind compression and excessive traction on the tissues. At the start of surgery, the patient is positioned in lithotomy, and an incision is made either in a curved fashion, following the ‘Mercedes-Benz standard’, or along the lower sacral midline. The external anal sphincter must be preserved during the procedure. The caudal anal ligament is then identified and transected to expose the tumour and separate the lesion from the rectum (mesentery). In cases of benign PPRTs, an identifiable mesorectal fascia typically exists between the mesorectal and retrorectal lesions. The surgeon must take care to avoid iatrogenic injury to the rectum during dissection. This can be facilitated by injecting a water pad to identify the separation gap and placing the index finger or gauze beneath the anal canal and rectum to apply forward pressure. In cases where the rectal wall adheres to the lesion and cannot be safely separated, a portion of the rectal wall may need to be excised along with the lesion. Additionally, the removal of the coccyx may reduce recurrence rates for tumours that are densely adhered to it, although this may result in chronic sacrococcygeal pain postoperatively.21

An intersphincteric approach can be considered for presacral PPRTs that are small in size, exhibit a benign tendency and are located at an extremely low position. At the commencement of the surgery, the patient is placed in a prone or truncated position. An inverted V-shaped or radial incision is subsequently made posterior to the anus to access the intersphincteric plane. The anal canal and internal sphincter are then bluntly separated from the external sphincter up to the level of the puborectalis muscle, allowing entry into the presacral space along the cephalad side, where a combination of sharp and blunt dissection techniques can be employed.

Transvaginal surgery is primarily employed for type II tumours, which are characterised by their small size and low positioning. This surgical approach is considered for tumours located beneath S5, provided that they do not exhibit dense adhesion to surrounding tissues or invasion into the coccyx and that their upper borders are palpable during vaginal or rectal examination. Generally, this technique demands advanced surgical skills due to the limited exposure within the surgical field.30 31

Recommendations: The posterior approach is suitable for type I PPRTs under S3. (Category 2B).

Combined approach

The abdominal approach combined with the sacral approach is typically employed for a type I PPRT with a large volume, characterised by an upper pole positioned higher than S4 and a lower pole closely associated with the sacrococcygeal region. This approach is particularly beneficial for masses that invade surrounding structures such as blood vessels, pelvic sidewalls, the sacrum, the ureter or the rectum.32 The rectum at the anorectal fissure, often referred to as the bare rectal area, poses significant challenges in visualisation and separation during surgical procedures because of its deep location and lack of mesenteric fat coverage, which increases the risk of injury. Throughout the operation, the principle of 'first easy, then difficult’ should be followed. Initially, an anterior approach can be used to separate the cranial aspect of the tumour up to the pelvic floor, providing a well-visualised and larger operating space for the pelvic organs, blood vessels, nerves and other structures. A posterior approach can subsequently be employed to dissect the caudal portion of the tumour beneath the pelvic floor muscles. Consequently, resection of the coccyx via the posterior approach can be minimised through the combined approach, thereby reducing postoperative complications such as caudal fossa effusion, incisional infection and long-term caudal pain.

The laparoscopic approach combined with transvaginal techniques can be considered for type II PPRTs, where the upper border (above S3) cannot be palpated during a triple examination, and the lower border remains below S5 after upward manipulation. Additionally, this approach is also viable for large type III PPRTs located low in the pelvis and in sexually experienced individuals, as it reduces the risk of incision-related complications compared with the abdominal approach combined with the sacral technique.

Recommendations: A combined approach is recommended for female patients with giant PPRTs that cannot be resected by a single surgical approach. (Category 2B).

Surgical complications and treatment

Rectal injury

Rectal injuries are observed predominantly in procedures involving an anterior approach. Tumour resection should be conducted as close to the tumour envelope as possible to minimise the risk of rectal injury. In the event of intraoperative rectal injury, the entire layer can initially be sutured using absorbable sutures, followed by embedding the muscle layer with plasma.24 For cases involving severe injury and inadequate repair, proximal mesenterostomy and the placement of an anal tube may be necessary.

Presacral haemorrhage

Presacral haemorrhage is predominantly observed in type I primary presacral tumours. The presacral venous plexus possesses numerous trafficking branches connecting to the intravertebral venous plexus and lacks venous valves. Notably, the inverted triangle of the venous network located in the anterior region of the S3–S5 vertebrae constitutes the 'danger triangle’ for presacral haemorrhage. Achieving haemostasis in this area is challenging, as the bleeding presacral veins often retract toward the sacral foramen or the cancellous bone of the sacrum. Surgeons should exercise caution to avoid exerting excessive traction on the tumour and surrounding tissues to prevent tearing. Bipolar electrocoagulation of the periosteum is a convenient and effective haemostatic technique, as it can effectively destroy the periosteum.33 Additionally, suture haemostasis may be attempted during a posterior approach. The filling compression method can be employed when other haemostatic strategies prove ineffective; however, caution is warranted, as this method may lead to tearing and other collateral injuries during compression, potentially exacerbating bleeding. For tumours characterised by a rich blood supply, significant volume and complex structure, adequate blood preparation prior to surgery is essential, and prepositioning an abdominal aortic balloon can be beneficial in minimising the risk of intraoperative bleeding.

Nerve injury

Pelvic nerve injury can lead to sensory‒motor disorders of the lower limbs, urinary dysfunction, defecation issues and sexual dysfunction. Posterior approach surgery carries a high risk of lateral pelvic nerve injury due to limited visualisation, whereas nerve injuries during anterior approach surgery often occur during haemostasis. Therefore, minimising intraoperative bleeding is crucial to ensure a clear surgical field. Furthermore, the pelvic nerve plexus is frequently located adjacent to or within the lateral rectal ligament, and excessive stretching of the lateral rectal ligament or rectosacral fascia may damage the branches of the sacral 2–4 parasympathetic nerves that converge into the pelvic plexus, resulting in urinary dysfunction. In the case of PPRTs that envelop nerves, the tumour should be incised longitudinally and carefully separated from the surrounding tissue along the nerve pathway, avoiding any transverse resection of the nerve.

Ureteral injury

The risk of ureteral injury may be increased by ureteral displacement due to compression from a PPRT or by adhesions to the ureter. Intraoperative detection of ureteral injury necessitates prompt intervention. In cases of delayed ureteral injury postsurgery, the treatment approach varies on the basis of the timing of detection; cystoscopy or ureteral stenting should be employed as needed, whereas one-stage repair and reconstruction or percutaneous nephrostomy could be considered appropriate. The preoperative placement of ureteral stents aids in the intraoperative identification of the ureter; however, the impact of this practice on reducing the risk of ureteral injury remains a topic of debate.34 35

Poor incision healing

Poor incision healing is more prevalent in surgeries that use the posterior approach, which can be attributed to several factors. First, the proximity of the sacrococcygeal incision to the anus increases the risk of contamination. Second, the accumulation of blood and fluid beneath the skin postoperatively can result in flap ischaemia, necrosis and subsequent infection. Additionally, the presence of a residual cavity following tumour resection, among other factors, can further impede the healing of the incision. To address these issues, pelvic floor tissues may be reconstructed after tumour resection to eliminate any residual cavities. Furthermore, adequate drainage should be implemented following the surgical procedure.

Anorectal dysfunction

Factors such as damage to the nerve plexus due to tumour compression, compression and traction from surrounding tissues, and surgical trauma may result in a diminished ability to sense defecation in the anorectal area, leading to an inability to fully control defecation. Attention should be directed toward protecting important organs, as well as the pelvic floor nerves and muscles, to avoid tissue damage caused by excessive clearance while ensuring that complete resection is achieved intraoperatively. Furthermore, providing scientific defecation training and dietary guidance and implementing standardised care for the perianal skin in the early postoperative stage are essential.

Adjuvant treatment

The efficacy of radiotherapy, targeted therapy and other treatments for malignant PPRTs is limited because of the rare nature of these tumours and their diverse pathological types. An adjuvant treatment plan can be routinely developed by referring to experiences with similar pathological tumours from the abdominal retroperitoneum or other regions in conjunction with molecular pathology testing, which is widely used in gynaecological malignancies.36 For complex PPRTs presenting at an advanced stage with metastatic lesions and significant resection challenges, a MDT approach should be employed to collaboratively formulate a treatment plan.

Prognosis

The prognosis for benign PPRTs is generally favourable following complete resection. However, initial surgical failure and intraoperative tumour rupture are two independent risk factors for recurrence.18 The local recurrence rate of retroperitoneal sarcomas remains significantly high, ranging from 24.0% to 54.0% within 5 years postoperation.37 38 There is a discernible histological pattern in the recurrence of retroperitoneal sarcomas: local recurrence occurs predominantly in highly differentiated liposarcomas and G1–G2 dedifferentiated liposarcomas, whereas distant metastasis is commonly observed in leiomyosarcomas. Both local recurrence and distant metastasis are noted in G3 dedifferentiated liposarcomas.37 Complete resection continues to be the primary option for locally recurrent tumours; however, this approach carries a greater risk and is complicated by prior surgical interventions. Therefore, the feasibility and timing of surgical intervention should be comprehensively assessed on the basis of the patient’s overall condition, imaging characteristics, tumour biological behaviour, initial surgery and recurrence interval. In cases of metastatic recurrent tumours, if the metastatic lesions can be completely resected, patients may experience prolonged survival. Conversely, MDT involvement is recommended when metastatic lesions are deemed unresectable.

Post-treatment management

There is no fixed duration or interval for follow-up care in cases of benign PPRTs. MRI examinations are recommended to be conducted 3– months postsurgery, followed by annual MRI assessments thereafter. In general, surgical intervention has a minimal impact on reproductive function. In contrast, for malignant PPRTs, follow-up evaluations are advised every 3 months after surgery for 2 years, every 6 months for the next 3 years and annually after the fifth year. These evaluations should include physical examinations, ultrasounds, MRIs and other relevant assessments.

Note: This consensus aims to provide guidance for the diagnosis and treatment of female PPRTs; however, it is not the sole practice guideline available. In clinical practice, it is essential to tailor implementations on the basis of individual characteristics, medical resources and the specific context of the medical institution. The development of this consensus does not negate the validity of other interventions. Additionally, there are limitations in the preparation of this expert consensus, which requires further updates and improvements in the future.

  • Collaborators: Ding Ma (Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology); Cailing Ma (The First Affiliated Hospital of Xinjiang Medical University); Shijun Wang (Xuanwu Hospital, Capital Medical University); Shixuan Wang (Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology); Yu Wang (the First Maternity and Infant Health Center of Shanghai); Liehong Wang (Qinghai Red Cross Hospital); Beihua Kong (Qilu Hospital of Shandong University); Keqin Hua (Obstetrics and Gynecology Hospital, Fudan University); Yang Xiang (Peking Union Medical College Hospital, Chinese Academy of Medical Sciences); Kaijiang Liu (Renji Hospital, Shanghai Jiao Tong University School of Medicine); Jinbo Liu (The First Affiliated Hospital of Zhengzhou University); Xueyan Liu (The First Affiliated Hospital of Zhengzhou University); Yang Sun (Fujian Provincial Cancer Hospital); Jing Sun (the First Maternity and Infant Health Center of Shanghai); Qin Yan (The First Maternity and Infant Health Center, Tongji University); Ling Li (Jiangxi Maternal and Child Health Center); Daoming Li (The First Affiliated Hospital of Zhengzhou University); Hong Yang (Xijing Hospital of Air Force Military Medical University); Hongying Yang (The Third Affiliated Hospital of Kunming Medical University); Ping Yang (The First Affiliated Hospital of Shihezi University); Weihua Tong (The First Hospital of Jilin University); Hui Wang (Obstetrics and Gynecology Hospital, Zhejiang University School of Medicine); Bingzhong Zhang (Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University); Anwei Lu (Shenzhen Hospital of Southern Medical University); Lihong Chen (Shanxi Province People’s Hospital); Ying Yue (The First Hospital of Jilin University); Shengtao Zhou (Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University); Yuanguang Meng (Seventh Medical Center of the General Hospital of the People’s Liberation Army); Weidong Zhao (The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine); Mengling Zhao (The First Affiliated Hospital of Zhengzhou University); Li Hong (People’s Hospital of Wuhan University); Honglan Zhu (People’s Hospital of Peking University); Desheng Yao (Tumor Hospital of Guangxi Medical University); Heli Li (The First Affiliated Hospital of Zhengzhou University); Bairong Xia (The First Hospital Affiliated to the University of Science and Technology of China (West)); Ruixia Guo (The First Affiliated Hospital of Zhengzhou University); Shan Kang (The Fourth Hospital of Hebei Medical University); Zhiqing Liang (Women’s and Children’s Hospital of Chongqing Medical University); Liping Han (The First Affiliated Hospital of Zhengzhou University), Xiaodong Cheng (Obstetrics and Gynecology Hospital of Zhejiang University School of Medicine), Dan Zi (Guizhou Provincial People’s Hospital), Rongyu Zang (Zhongshan Hospital of Fudan University), Fengxia Xue (Tianjin Medical University General Hospital).

  • Contributors: The concept of this work was developed by RG. The initial draft of the manuscript was written by XL, JL, HL and MZ. WT and DL supervised the research and provided critical guidance throughout the project. The manuscript was reviewed and revised by YX, LH, RZ, ZL and FX. All authors approved the final version of the manuscript.

  • Funding: This study was supported by the Henan Provincial Health Commission Key Project of Science and Technology Research (SBGJ202302074) and the Henan Provincial Key Support Discipline Project for 2024—Gynaecological and Obstetric Surgery.

  • Competing interests: YX, FX and DM have served as an editorial member of GOCM. All other authors declare no competing interest.

  • Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review: Not commissioned; externally peer reviewed.

  • Author note: This consensus aims to provide guidance for the diagnosis and treatment of female PPRTs; however, it is not the sole practice guideline available. In clinical practice, it is essential to tailor implementations on the basis of individual characteristics, medical resources and the specific context of the medical institution. The development of this consensus does not negate the validity of other interventions. Additionally, there are limitations in the preparation of this expert consensus, which requires further updates and improvements in the future. Supervising experts Beihua Kong (Qilu Hospital, Shandong University); Ding Ma (Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology).

Ethics statements

Patient consent for publication:
Ethics approval:

All data for this expert consensus are from published literature. Therefore, an ethical approval is waived.

  1. close Mengmeng P, Liuxia L, Ruixia G, et al. Diagnosis and treatment of female primary pelvic retroperitoneal tumor: a clinical analysis of 120 cases. J Henan Surg 2019; 25:28–31.
  2. close Chenghua L, Rong L, Shaobai S, et al. Surgery for extraperitoneal pelvic neoplasms. Zhonghua Wai Ke Za Zhi 2004;
  3. close Liu X, Zhao M, Fu H, et al. The surgical treatment of female primary pelvic retroperitoneal tumours: A retrospective study of 99 patients from a single centre in China. Robotics Computer Surgery 2024; 20.
  4. close Cancer IAfRo. WHO classification of tumours editorial board. Soft tissue and bone tumours 2020;
  5. close Ming X, Songfeng X, Xiuchun Y, et al. Surgical treatment strategies for pelvic extraperitoneal soft tissue tumors. Chin J Bone Joint 2012; 1:119–22.
  6. close Aubert M, Mege D, Parc Y, et al. Surgical management of retrorectal tumors: A french multicentric experience of 270 consecutives cases. Ann Surg 2021; 274:766–72.
  7. close Singer MA, Cintron JR, Martz JE, et al. Retrorectal cyst: A rare tumor frequently misdiagnosed. J Am Coll Surg 2003; 196:880–6.
  8. close Mohammed SA, Kazali BA, Ibrahim BM, et al. Primary retroperitoneal mature teratoma in a young female: Case report. Int J Surg Case Rep 2024; 115.
  9. close Qian X, Jiumei C. Analysis of 58 clinical cases misdiagnosed as gynecological tumors. Int J Gynecol Obstet 2023; 50:297–301.
  10. close Chao C, Ying Z. Analysis of clinical characteristics of retroperitoneal tumors misdiagnosed as gynecologic tumors. Beijing Med J 2022; 44:273–5.
  11. close Yuxia L. Exploration of the value of ultrasound in the differential diagnosis of pelvic masses and pelvic retroperitoneal tumor. Imaging Res Med Appl 2020; 4:242–3.
  12. close Ying Z, Haiyun H, Lilu N, et al. Ultrasonic findings of female pelvic retroperitoneal cyst. Chin J Med Imaging Technol 2023; 39:1909–10.
  13. close Fischerova D, Santos G, Wong L, et al. Imaging in gynecological disease (26): clinical and ultrasound characteristics of benign retroperitoneal pelvic peripheral-nerve-sheath tumors. Ultrasound Obstet Gynecol 2023; 62:727–38.
  14. close Yun L, Jufang D, Rong L, et al. Diagnostic values of ultrasound and MRI in differentiating female pelvic masses. Ba Chu Medi 2023; 6:75–9.
  15. close Toh JWT, Morgan M. Management approach and surgical strategies for retrorectal tumours: a systematic review. Colorectal Dis 2016; 18:337–50.
  16. close Association CM, Association CSoCM, Association JoCM. Expert consensus on treatment of Retroperitoneal tumors in china (Edition 2019). Zhonghua Zhong Liu Za Zhi 2019; 41:728–33.
  17. close Maurice MJ, Yih JM, Ammori JB, et al. Predictors of surgical quality for retroperitoneal sarcoma: Volume matters. J Surg Oncol 2017; 116:766–74.
  18. close Zhang D, Sun Y, Lian L, et al. Long‐term surgical outcomes after resection of presacral tumours and risk factors associated with recurrence. Colorectal Dis 2021; 23:2301–10.
  19. close Doepker MP, Hanna KH, Thompson ZJ, et al. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures. J Surg Oncol 2016; 113:103–7.
  20. close Swallow CJ, Strauss DC, Bonvalot S, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: An updated consensus approach from the transatlantic australasian RPS working group. Ann Surg Oncol 2021; 28:7873–88.
  21. close Wolpert A, Beer-Gabel M, Lifschitz O, et al. The management of presacral masses in the adult. Tech Coloproctol 2002; 6:43–9.
  22. close Chunyi H, Jianhui W. Chinese expert consensus on the diagnosis and treatment of primary retroperitoneal soft tissue sarcoma. Chin J Pract Surg 2019; 39:526–32.
  23. close Oh JK, Yang MS, Yoon DH, et al. Robotic resection of huge presacral tumors: case series and comparison with an open resection. J Spinal Disord Tech 2014; 27:E151–4.
  24. close Huicheng X, Dan W, Yanzhou W, et al. Laparoscopic resection for sacrococcygeal teratoma: report of 26 cases. J Third Mil Med Univ 2010; 32:1220–2.
  25. close Chen Y, Xu H, Li Y, et al. Laparoscopic resection of presacral teratomas. J Minim Invasive Gynecol 2008; 15:649–51.
  26. close Yun H, Yufeng Z. Efficacy analysis of laparoscopic surgery for primary retroperitoneal tumors. Journal of Henan Surgery 2020; 26:40–1.
  27. close Xueyan L, Mengling Z, Hanlin F, et al. Comparison of robot-assisted and traditional laparoscopic surgery complications in female primary pelvic retroperitoneal tumors and analysis of related risk factors. Progress in Modern Obstetrics and Gynecology 2023; 32:108–12.
  28. close Xueyan L, Mengling Z, Yana L, et al. Comparative analysis of the efficacy between robot-assisted laparoscopic and conventional laparoscopic resection for women with primary pelvic retroperitoneal tumors. Chin J Pract Gynecol Obstet 2022; 38:946–9.
  29. close Li Z, Lu M. Presacral tumor: Insights from a decade’s experience of this rare and diverse disease. Front Oncol 2021; 11:639028.
  30. close Jing X. Classification and operative approaches of adult female presacral space tumor. Chin J Minim Invasive Surg 2017; 17:24–6.
  31. close Meng G, Fujin S, Xuexian X, et al. Misdiagnosis analysis and treatment of retroperitoneal teratoma in adults. Clin Misdiagn Mistreat 2019; 32:12–7.
  32. close Cancer Prevention and Treatment Expert Committee C-SMEA, Control SGoCVaQ, Association CCCoCMD. Chinese expert consensus on standardized treatment of presacral cysts. Zhonghua Zhong Liu Za Zhi 2021; 43:1034–42.
  33. close Meng L, Yong-wei S, Qing X, et al. High-frequency electrocautery in the treatment of massive hemorrhage of presacral venous plexus. Zhong Hua Xiao Hua Wai Ke Za Zhi 2008; 07:354–5.
  34. close Gurumurthy M, McGee AE, Saraswat L, et al. Prophylactic ureteric catheterisation during complex gynaecological surgery: A systematic review and meta-analysis. BJOG 2024; 131:1341–51.
  35. close Yanagisawa T, Mori K, Quhal F, et al. Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis. BJU Int 2023; 131:540–52.
  36. close Tonti N, Golia D’Augè T, Cuccu I, et al. The role of tumor biomarkers in Tailoring the approach to advanced ovarian cancer. Int J Mol Sci 2024; 25:11239.
  37. close Gronchi A, Strauss DC, Miceli R, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): A report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg 2016; 263:1002–9.
  38. close Toulmonde M, Bonvalot S, Méeus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol 2014; 25:735–42.

Crossmark logoCrossmark logo
  • Received: 2 June 2025
  • Accepted: 17 November 2025
  • First published: 12 December 2025

Altmetric

Altmetric scores reflect online attention articles receive, shown as a central number with coloured threads for each source

Dimensions

Dimensions shows where and when an article has been cited, helping readers understand its academic influence over time